Who’s really leading the pack this week in crypto? If you’ve been watching Kaspa, you’ve probably seen some mixed vibes in the air. According to fresh news from CryptoDaily, the community’s been holding its breath over Binance listing delays, while rival DAG makes bold claims of outpacing Kaspa’s powerful 10,000 TPS. Meanwhile, over at Quant, the token continues to quietly maintain its ground with steady market cap and trading volume—even as it holds back from wild swings.

So while Kaspa tries to get past the centralized exchange roadblocks and Quant strengthens its foundation, another name is making serious waves beneath the surface—Qubetics. With its presale now in Stage 27, over $15.4 million raised, and an app suite that includes a powerful dev-first tool called QubeQode IDE, Qubetics is gaining attention fast. And when it comes to the top cryptos to invest in this week, it’s looking like a no-brainer.

This isn’t just some short-term token hype either. Qubetics is building the infrastructure Web3 developers actually need. And if you missed Ethereum or Solana early, this might be your reset button. The presale price is sitting at $0.1300 for now—but each Sunday brings a 10% hike, and the ROI projections? Absolutely insane.

Qubetics Is Smashing Dev Barriers with QubeQode IDE

Here’s the thing about building on blockchain—it’s a pain for most developers. From complicated APIs to clunky tooling, it can feel like Web2 devs are being asked to switch from Tesla to tricycle. Qubetics fixes that problem with QubeQode IDE, a full-stack dev environment that brings AI, interoperability, and EVM compatibility into one simple-to-use ecosystem.

Whether you’re a startup founder trying to deploy a multi-chain dApp or a solo coder tinkering with smart contracts, QubeQode lets you build faster and smarter without needing a PhD in Solidity. With built-in AI suggestions, gas estimation tools, and code auto-completion, it’s basically VSCode for the blockchain age—on steroids.

What makes this truly valuable is how it connects to Qubetics’ Web3 aggregation layer. Devs can deploy across Ethereum, Solana, BNB Chain, Avalanche, and more—without needing separate wallets, bridges, or different setups. You’re writing once and launching everywhere. That kind of flexibility is why community members are starting to call Qubetics one of the top cryptos to invest in this week—not because of a buzzword, but because the tech solves a very real dev problem.

Presale ROI Is Turning Heads—Stage 27 Is Getting Crowded

Let’s talk money. Because at the end of the day, tech is cool—but ROI is cooler. Qubetics is currently in Stage 27 of its crypto presale, with $TICS tokens priced at $0.1300. So far, the presale has brought in $15.4 million, locked down 503 million tokens sold, and onboarded 23,700+ holders. Every week, the price jumps by 10% at Sunday 12 AM, so early participants are cashing in while others stall.

Here’s what the numbers look like:

  • At $1 post-presale, you’re looking at a 669.13% ROI
  • If $TICS hits $5, the ROI jumps to 3,745.66%
  • At $10, you’re looking at a massive 7,591.33%
  • And if $TICS reaches $15 post-mainnet launch? That’s a 11,436.99% ROI

Let’s say you drop $1,000 today at $0.1300—you’d walk away with 7,692 tokens. If $TICS hits $10 in 2025, you’re sitting on $76,920. And if it hits $15? You’re looking at $115,380. Not bad for getting in before the exchanges even catch on.

With the mainnet set to launch in Q2 2025, the countdown to mass exposure has already started. If you’re serious about finding the top cryptos to invest in this week, you won’t want to wait until Stage 30 or beyond. This rocket’s already on the launchpad.

Kaspa Faces Binance Stall as DAG Brings the Heat

Kaspa made waves by becoming one of the fastest chains out there with its 10,000 transactions per second (TPS) performance benchmark—but this week, the community’s facing a bit of a curveball. According to CryptoDaily, Binance has stalled the listing process, leaving many to question what’s holding it back while other projects—like DAG—start making noise.

In a recent AMA, the dev team made some bold claims: not only are they preparing to beat Kaspa’s TPS numbers, but they’re also promising faster confirmation times and broader utility. That’s a lot of pressure for Kaspa, especially when much of its momentum has come from transaction speed and efficient block finality.

While community members remain hopeful that Binance will move forward, this delay has created a sense of limbo. And when a project’s biggest bullish catalyst is paused, even loyal participants start looking for better short-term entry points—which is exactly why Qubetics, with its live presale, is suddenly the hot option this week.

Quant Gains Quiet Strength with Solid Tokenomics

Unlike Kaspa’s flashy TPS or Qubetics’ aggressive ROI model, Quant (QNT) is playing a long, quiet game. As of March 24, according to CoinMarketCap, Quant is trading in the $120 range with a market cap of $1.45 billion and a total circulating supply of 14.5 million QNT. That’s a super tight token supply, which has helped it maintain value even during volatile weeks.

Quant’s Overledger platform still acts as a critical bridge for banks, enterprises, and financial institutions looking to tap into blockchain without losing compliance or reliability. It’s not targeting crypto-native users but rather the legacy system—and that’s a different lane entirely.

While some might see Quant as too “slow and steady,” others view it as a hedge against market noise. It’s not dropping 30% overnight or pumping on Twitter hype. And in a week where Binance delays and flashy promises dominate headlines, Quant’s stable performance stands out. Still, when it comes to Top Cryptos to Invest in This Week, Qubetics brings the kind of high-reward momentum that Quant just doesn’t match at this stage.

Conclusion: Qubetics Steals the Spotlight This Week

So what do we have here? Kaspa is riding past glory on its speed records but is now waiting on Binance with its community in limbo. Quant is holding steady, backed by serious utility but lacking the explosive upside this week’s alpha chasers are after. And then there’s Qubetics—powering into Stage 27 with a utility-rich dev suite, multi-chain reach, and a ticking ROI bomb that’s catching fire in crypto circles.

Qubetics isn’t just another token launch, it’s one of the top cryptos to invest in this week. It’s a platform solving real problems for builders and developers across the entire blockchain spectrum. And with up to 11,436.99% ROI on the table, this is the moment where people either act—or scroll past what could be their biggest opportunity of 2025.

There’s still time to grab $TICS before the price jumps again—but not much. The next price hike hits this Sunday at midnight, and the presale is racing toward its final stages. Don’t just read about others cashing in. This is your sign to join the Qubetics presale while the rocket is still on the ground.

For More Information:

Qubetics: https://qubetics.com 

Presale: https://buy.qubetics.com/

Telegram: https://t.me/qubetics 

Twitter: https://x.com/qubetics 

FAQs

Why is Qubetics one of the top cryptos to invest in this week?

Qubetics stands out for its real-world developer utility through QubeQode IDE, plus its interoperability layer and aggressive presale ROI potential, which makes it highly attractive for early participants.

How much can I make by investing in Qubetics today?

If you invest $1,000 at the current price of $0.1300, you receive 7,692 $TICS. If the token hits $10, that becomes $76,920. At $15, it jumps to $115,380—showing just how big the upside is during presale.

What makes Qubetics different from Kaspa and Quant?

While Kaspa focuses on TPS and Quant builds institutional bridges, Qubetics delivers developer-centric tools, cross-chain support, and early ROI potential—making it the most compelling choice for this week.

Disclaimer: Any information written in this press release does not constitute investment advice. Optimisus does not, and will not endorse any information about any company or individual on this page. Readers are encouraged to do their own research and base any actions on their own findings, not on any content written in this press release. Optimisus is and will not be responsible for any damage or loss caused directly or indirectly by the use of any content, product, or service mentioned in this press release.

Tags